United States · FDA National Drug Code directory
Lynparza
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0310-0668_0142c57f-6211-4638-8c48-c215686871b8
- Product NDC
- 0310-0668
- Form
- TABLET, FILM COATED
- Composition / generic term
- olaparib
- Labeler
- AstraZeneca Pharmaceuticals LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170817
- Source listing expiry
- 20261231
Source-listed ingredients
- OLAPARIB — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET, FILM COATED in 1 BOTTLE (0310-0668-12) · 0310-0668-12
- 60 TABLET, FILM COATED in 1 BOTTLE (0310-0668-60) · 0310-0668-60
- 60 TABLET, FILM COATED in 1 BOTTLE (0310-0668-95) · 0310-0668-95
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →